Safety in a Phase 1 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating Two Adenovirus HIV Vaccines in Three Different Geographic Regions
Background: Homologous and heterologous prime-boost regimens were compared using two adenovirus vectors (Ad26.EnvA. 01 [Ad26] and Ad35-EnvA [Ad35]) in the USA, East Africa and South Africa. This is the first trial using either vector for an HIV preventive vaccine in Africa. Safety data between these...
Gespeichert in:
| Veröffentlicht in: | AIDS research and human retroviruses 2013-11, Vol.29 (11), p.A-148 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 148 |
|---|---|
| container_issue | 11 |
| container_start_page | A |
| container_title | AIDS research and human retroviruses |
| container_volume | 29 |
| creator | Karita, E Mutua, G Bekker, L Gray, G Page-Shipp, L Baden, L Bayingana, R Nyombayire, J Anzala, O Nyasani, D Roux, S Mangenya, N Laher, F Mambe, M Innes, C Mngadi, K Walsh, S Johnson, J Dolin, R Stevens, G Grunenberg, N Barouch, D Fast, P Laufer, D |
| description | Background: Homologous and heterologous prime-boost regimens were compared using two adenovirus vectors (Ad26.EnvA. 01 [Ad26] and Ad35-EnvA [Ad35]) in the USA, East Africa and South Africa. This is the first trial using either vector for an HIV preventive vaccine in Africa. Safety data between these regions were compared. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1566837059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1566837059</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_15668370593</originalsourceid><addsrcrecordid>eNqVjctOAkEQAPegifj4hz56cJNhyOLuUQHFG8ENV9LM9O62GaZxHhj9D__XkPADniqVVFIXxUjVdVNqrZur4jrGD6VUo3U1Kn7fsaP0DewBYTVgJBjDGr2VPf-QfYC55J2j8tmxtydfOTS0k3ImPgVxjiy0gdHB4oguY2LfQ_sl8GTJy5FDjrB828AGjWFP8TRqh0AEc-46CuQTvJL0AQ8DG1hTz-LjbXHZoYt0d-ZNcf-yaGfL8hDkM1NM2z1HQ86hJ8lxO66m03ryqKpm8o_0D0bJWlM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1566837059</pqid></control><display><type>article</type><title>Safety in a Phase 1 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating Two Adenovirus HIV Vaccines in Three Different Geographic Regions</title><source>Mary Ann Liebert Online Subscription</source><source>Alma/SFX Local Collection</source><creator>Karita, E ; Mutua, G ; Bekker, L ; Gray, G ; Page-Shipp, L ; Baden, L ; Bayingana, R ; Nyombayire, J ; Anzala, O ; Nyasani, D ; Roux, S ; Mangenya, N ; Laher, F ; Mambe, M ; Innes, C ; Mngadi, K ; Walsh, S ; Johnson, J ; Dolin, R ; Stevens, G ; Grunenberg, N ; Barouch, D ; Fast, P ; Laufer, D</creator><creatorcontrib>Karita, E ; Mutua, G ; Bekker, L ; Gray, G ; Page-Shipp, L ; Baden, L ; Bayingana, R ; Nyombayire, J ; Anzala, O ; Nyasani, D ; Roux, S ; Mangenya, N ; Laher, F ; Mambe, M ; Innes, C ; Mngadi, K ; Walsh, S ; Johnson, J ; Dolin, R ; Stevens, G ; Grunenberg, N ; Barouch, D ; Fast, P ; Laufer, D</creatorcontrib><description>Background: Homologous and heterologous prime-boost regimens were compared using two adenovirus vectors (Ad26.EnvA. 01 [Ad26] and Ad35-EnvA [Ad35]) in the USA, East Africa and South Africa. This is the first trial using either vector for an HIV preventive vaccine in Africa. Safety data between these regions were compared.</description><identifier>ISSN: 0889-2229</identifier><language>eng</language><subject>Adenovirus ; Human immunodeficiency virus ; Retrovirus</subject><ispartof>AIDS research and human retroviruses, 2013-11, Vol.29 (11), p.A-148</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Karita, E</creatorcontrib><creatorcontrib>Mutua, G</creatorcontrib><creatorcontrib>Bekker, L</creatorcontrib><creatorcontrib>Gray, G</creatorcontrib><creatorcontrib>Page-Shipp, L</creatorcontrib><creatorcontrib>Baden, L</creatorcontrib><creatorcontrib>Bayingana, R</creatorcontrib><creatorcontrib>Nyombayire, J</creatorcontrib><creatorcontrib>Anzala, O</creatorcontrib><creatorcontrib>Nyasani, D</creatorcontrib><creatorcontrib>Roux, S</creatorcontrib><creatorcontrib>Mangenya, N</creatorcontrib><creatorcontrib>Laher, F</creatorcontrib><creatorcontrib>Mambe, M</creatorcontrib><creatorcontrib>Innes, C</creatorcontrib><creatorcontrib>Mngadi, K</creatorcontrib><creatorcontrib>Walsh, S</creatorcontrib><creatorcontrib>Johnson, J</creatorcontrib><creatorcontrib>Dolin, R</creatorcontrib><creatorcontrib>Stevens, G</creatorcontrib><creatorcontrib>Grunenberg, N</creatorcontrib><creatorcontrib>Barouch, D</creatorcontrib><creatorcontrib>Fast, P</creatorcontrib><creatorcontrib>Laufer, D</creatorcontrib><title>Safety in a Phase 1 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating Two Adenovirus HIV Vaccines in Three Different Geographic Regions</title><title>AIDS research and human retroviruses</title><description>Background: Homologous and heterologous prime-boost regimens were compared using two adenovirus vectors (Ad26.EnvA. 01 [Ad26] and Ad35-EnvA [Ad35]) in the USA, East Africa and South Africa. This is the first trial using either vector for an HIV preventive vaccine in Africa. Safety data between these regions were compared.</description><subject>Adenovirus</subject><subject>Human immunodeficiency virus</subject><subject>Retrovirus</subject><issn>0889-2229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqVjctOAkEQAPegifj4hz56cJNhyOLuUQHFG8ENV9LM9O62GaZxHhj9D__XkPADniqVVFIXxUjVdVNqrZur4jrGD6VUo3U1Kn7fsaP0DewBYTVgJBjDGr2VPf-QfYC55J2j8tmxtydfOTS0k3ImPgVxjiy0gdHB4oguY2LfQ_sl8GTJy5FDjrB828AGjWFP8TRqh0AEc-46CuQTvJL0AQ8DG1hTz-LjbXHZoYt0d-ZNcf-yaGfL8hDkM1NM2z1HQ86hJ8lxO66m03ryqKpm8o_0D0bJWlM</recordid><startdate>20131101</startdate><enddate>20131101</enddate><creator>Karita, E</creator><creator>Mutua, G</creator><creator>Bekker, L</creator><creator>Gray, G</creator><creator>Page-Shipp, L</creator><creator>Baden, L</creator><creator>Bayingana, R</creator><creator>Nyombayire, J</creator><creator>Anzala, O</creator><creator>Nyasani, D</creator><creator>Roux, S</creator><creator>Mangenya, N</creator><creator>Laher, F</creator><creator>Mambe, M</creator><creator>Innes, C</creator><creator>Mngadi, K</creator><creator>Walsh, S</creator><creator>Johnson, J</creator><creator>Dolin, R</creator><creator>Stevens, G</creator><creator>Grunenberg, N</creator><creator>Barouch, D</creator><creator>Fast, P</creator><creator>Laufer, D</creator><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20131101</creationdate><title>Safety in a Phase 1 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating Two Adenovirus HIV Vaccines in Three Different Geographic Regions</title><author>Karita, E ; Mutua, G ; Bekker, L ; Gray, G ; Page-Shipp, L ; Baden, L ; Bayingana, R ; Nyombayire, J ; Anzala, O ; Nyasani, D ; Roux, S ; Mangenya, N ; Laher, F ; Mambe, M ; Innes, C ; Mngadi, K ; Walsh, S ; Johnson, J ; Dolin, R ; Stevens, G ; Grunenberg, N ; Barouch, D ; Fast, P ; Laufer, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_15668370593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adenovirus</topic><topic>Human immunodeficiency virus</topic><topic>Retrovirus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karita, E</creatorcontrib><creatorcontrib>Mutua, G</creatorcontrib><creatorcontrib>Bekker, L</creatorcontrib><creatorcontrib>Gray, G</creatorcontrib><creatorcontrib>Page-Shipp, L</creatorcontrib><creatorcontrib>Baden, L</creatorcontrib><creatorcontrib>Bayingana, R</creatorcontrib><creatorcontrib>Nyombayire, J</creatorcontrib><creatorcontrib>Anzala, O</creatorcontrib><creatorcontrib>Nyasani, D</creatorcontrib><creatorcontrib>Roux, S</creatorcontrib><creatorcontrib>Mangenya, N</creatorcontrib><creatorcontrib>Laher, F</creatorcontrib><creatorcontrib>Mambe, M</creatorcontrib><creatorcontrib>Innes, C</creatorcontrib><creatorcontrib>Mngadi, K</creatorcontrib><creatorcontrib>Walsh, S</creatorcontrib><creatorcontrib>Johnson, J</creatorcontrib><creatorcontrib>Dolin, R</creatorcontrib><creatorcontrib>Stevens, G</creatorcontrib><creatorcontrib>Grunenberg, N</creatorcontrib><creatorcontrib>Barouch, D</creatorcontrib><creatorcontrib>Fast, P</creatorcontrib><creatorcontrib>Laufer, D</creatorcontrib><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>AIDS research and human retroviruses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karita, E</au><au>Mutua, G</au><au>Bekker, L</au><au>Gray, G</au><au>Page-Shipp, L</au><au>Baden, L</au><au>Bayingana, R</au><au>Nyombayire, J</au><au>Anzala, O</au><au>Nyasani, D</au><au>Roux, S</au><au>Mangenya, N</au><au>Laher, F</au><au>Mambe, M</au><au>Innes, C</au><au>Mngadi, K</au><au>Walsh, S</au><au>Johnson, J</au><au>Dolin, R</au><au>Stevens, G</au><au>Grunenberg, N</au><au>Barouch, D</au><au>Fast, P</au><au>Laufer, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety in a Phase 1 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating Two Adenovirus HIV Vaccines in Three Different Geographic Regions</atitle><jtitle>AIDS research and human retroviruses</jtitle><date>2013-11-01</date><risdate>2013</risdate><volume>29</volume><issue>11</issue><spage>A</spage><epage>148</epage><pages>A-148</pages><issn>0889-2229</issn><abstract>Background: Homologous and heterologous prime-boost regimens were compared using two adenovirus vectors (Ad26.EnvA. 01 [Ad26] and Ad35-EnvA [Ad35]) in the USA, East Africa and South Africa. This is the first trial using either vector for an HIV preventive vaccine in Africa. Safety data between these regions were compared.</abstract></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0889-2229 |
| ispartof | AIDS research and human retroviruses, 2013-11, Vol.29 (11), p.A-148 |
| issn | 0889-2229 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1566837059 |
| source | Mary Ann Liebert Online Subscription; Alma/SFX Local Collection |
| subjects | Adenovirus Human immunodeficiency virus Retrovirus |
| title | Safety in a Phase 1 Randomized, Double-Blinded, Placebo-Controlled Trial Evaluating Two Adenovirus HIV Vaccines in Three Different Geographic Regions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T00%3A41%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20in%20a%20Phase%201%20Randomized,%20Double-Blinded,%20Placebo-Controlled%20Trial%20Evaluating%20Two%20Adenovirus%20HIV%20Vaccines%20in%20Three%20Different%20Geographic%20Regions&rft.jtitle=AIDS%20research%20and%20human%20retroviruses&rft.au=Karita,%20E&rft.date=2013-11-01&rft.volume=29&rft.issue=11&rft.spage=A&rft.epage=148&rft.pages=A-148&rft.issn=0889-2229&rft_id=info:doi/&rft_dat=%3Cproquest%3E1566837059%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1566837059&rft_id=info:pmid/&rfr_iscdi=true |